Evidence map›Paper›PMID 32788262›Full record

Observational studyInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2020

SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer.

Luis Chiva, Vanna Zanagnolo, Denis Querleu, Nerea Martin-Calvo, Juan Arévalo-Serrano, Mihai Emil Căpîlna, Anna Fagotti, Ali Kucukmetin, Constantijne Mom, Galina Chakalova and 39 more

Registry-linked trialOpen access · bronzeAbstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06836869 (A Multicenter, Non-inferiority Trial to Compare the Effectiveness and Safety of Laparoscopic Radical Hysterectomy Incorporating Modified Tumor-free Techniques Versus Abdominal Radical Hysterectomy in Patients With Stage IB2 Cervical Cancer), which is not on this map. Cited by 124 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 6 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06836869 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Multicenter, Non-inferiority Trial to Compare the Effectiveness and Safety of Laparoscopic Radical Hysterectomy Incorporating Modified Tumor-free Techniques Versus Abdominal Radical Hysterectomy in Patients With Stage IB2 Cervical Cancer

TypeinterventionalSponsorPeking Union Medical College HospitalRan2025 to 2032Enrolled524ConditionsCervical Cancer Stage IB2ArmsLaparoscopic radical hysterectomy incorporating modified tumor-free techniques, Abdominal radical hysterectomy
3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 6 syntheses or guidelines pooled it, 292 citations in OpenAlex.

  1. SEOM-GEICO Clinical Guidelines on cervical cancer (2023).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Guideline
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023
    Trial
  8. Trial
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

49 authors at 20 institutions in 22 countries.

Luis ChivaDepartment of Obstetrics and Gynecology, Clinica Universidad de Navarra, Madrid, Spain lchiva@unav.es.ORCID 0000-0002-1908-3251
Vanna ZanagnoloIstituto Europeo di Oncologia, Milano, Italy.
Denis QuerleuSurgery, Institut Bergonie, Bordeaux, France.
Nerea Martin-CalvoDepartment of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain.
Juan Arévalo-SerranoPrincipe de Asturias University Hospital, Alcala de Henares, Spain.
Mihai Emil CăpîlnaEmergency County Hospital, Targu Mures, Romania.
Anna FagottiPoliclinico A Gemelli, Roma, Italy.
Ali KucukmetinQueen Elizabeth Hospital, Gateshead, UK.
Constantijne MomAmsterdam University Medical Centre, Amsterdam, Netherlands.
Galina ChakalovaUniversity Oncologic Hospital, Sofia, Bulgaria.
Shamistan AliyevNational Center of Oncology, Baku, Azerbaijan.
Mario MalzoniCenter for Advanced Endoscopic Gynecologic Surgery, Avellino, Italy.
Fabrice NarducciGynecology, Centre Oscar Lambret, Lille, France.ORCID 0000-0001-5809-3535
Octavio ArencibiaUniversity Maternal Hospital Canary Islands, Las Palma, Spain.
Francesco RaspagliesiFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Tayfun ToptasSaglik Bilimleri University Antalya Research and Training Hospital, Antalya, Turkey.
David CibulaDepartment of Obstetrics and Gynecology, University of Prague, Prague, Czech Republic.
Dilyara KaidarovaOncogynecology, Kazahskij Naucno-issledovatel'skij Institut Onkologii i Radiologii, Almaty, Kazakhstan.
Mehmet Mutlu MeydanliDepartment of Gynecologic Oncology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey.ORCID 0000-0001-6763-9720
Mariana TavaresIPO-PORTO, Porto, Portugal.
Dmytro GolubLISOD - Israeli Oncological Hospital, Kyiv, Ukraine.
Anna Myriam PerroneAzienda Ospedaliero-Universitaria di Bologna Policlinico SantOrsola-Malpighi, Bologna, Italy.ORCID 0000-0003-3140-4772
Robert PokaObstetrics and Gynecology; Unit of Gynecologic Oncology; Institute of Obstetrics and Gynecology; Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Dimitrios TsolakidisGeneral Hospital of Thessaloniki Papageorgiou, Thessaloniki, Greece.
Goran VujićClinical Hospital Center, Zagreb, Croatia.
Marcin A JedrykaOncological Gynecology, Lower Silesian Cancer Center, Wroclaw, Poland.ORCID 0000-0001-8935-0311
Petra L M ZusterzeelGynecological Oncology, Radboudumc, Nijmegen, Netherlands.
Jogchum Jan BeltmanGynaecology, LUMC, Leiden, Netherlands.
Frederic GoffinObstetrics and Gynecology, University of Liege, Liege, Belgium.
Dimitrios HaidopoulosDivision of Gynecologic Oncology, 1st Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Herman HallerClinical Hospital Center Rijeka, Rijeka, Croatia.
Robert JachDepartment of Gynecology and Oncology, Jagiellonian University, Krakow, Poland.
Iryna YezhovaLviv Oncology Center, Lviv, Ukraine.
Igor BerlevNorth-Western State Medical University. N.N. Petrov Research Institute of Oncology, St Petersburg, Russia.
Margarida BernardinoInstituto Português de Oncologia de Lisboa, Lisboa, Portugal.
Rasiah BharathanUniversity Hospitals of Leicester NHS Trust, Leicester, UK.
Maximilian LannerMedical University of Graz, Graz, Steiermark, Austria.
Minna M MaenpaaObstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.
Vladyslav SukhinOncogynecology, Grigorev Institute for Radiology, Kharkiv, Ukraine.ORCID 0000-0002-4403-3707
Jean-Guillaume FeronInstitut Curie, Paris, Île-de-France, France.
Robert FruscioDepartment of Medicine and Surgery, University of Milan-Bicocca, Milano, Italy.
Kersti KukkNorth Estonia Medical Centre, Tallinn, Estonia.
Jordi PonceBellvitge University Hospital, L'Hospitalet de Llobregat, Catalunya, Spain.
Jose Angel MinguezObstetrics and Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Daniel Vázquez-VicenteObstetrics and Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.ORCID 0000-0002-9618-5606
Teresa CastellanosObstetrics and Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Enrique ChaconObstetrics and Gynecology, Universidad de Navarra, Pamplona, Spain.
Juan Luis AlcazarObstetrics and Gynecology, School of Medicine; University of Navarra, Pamplona, Spain.ORCID 0000-0002-9700-0853
SUCCOR study Group
Clinica Universidad de Navarra · ESUniversidad de Navarra · ESIPO Porto · PTUniversity of Liège · BEHospital Universitario Príncipe de Asturias · ESVA Fanarjian National Center of Oncology · AZAgostino Gemelli University Polyclinic · ITAntalya Bilim University · TRAzienda Ospedaliera San Gerardo · ITBellvitge University Hospital · ESCentre Oscar Lambret · FREuropean Institute of Oncology · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGynecologic Oncology Group · USInstitut Bergonié · FRInstitut Curie · FRIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITJagiellonian University · PLKazakh Institute of Oncology and Radiology · KZLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMinimally invasive surgery in cervical cancer has demonstrated in recent publications worse outcomes than open surgery. The primary objective of the SUCCOR study, a European, multicenter, retrospective, observational cohort study was to evaluate disease-free survival in patients with stage IB1 (FIGO 2009) cervical cancer undergoing open vs minimally invasive radical hysterectomy. As a secondary objective, we aimed to investigate the association between protective surgical maneuvers and the risk of relapse.

methodsWe obtained data from 1272 patients that underwent a radical hysterectomy by open or minimally invasive surgery for stage IB1 cervical cancer (FIGO 2009) from January 2013 to December 2014. After applying all the inclusion-exclusion criteria, we used an inverse probability weighting to construct a weighted cohort of 693 patients to compare outcomes (minimally invasive surgery vs open). The first endpoint compared disease-free survival at 4.5 years in both groups. Secondary endpoints compared overall survival among groups and the impact of the use of a uterine manipulator and protective closure of the colpotomy over the tumor in the minimally invasive surgery group.

resultsMean age was 48.3 years (range; 23-83) while the mean BMI was 25.7 kg/m

conclusionsMinimally invasive surgery in cervical cancer increased the risk of relapse and death compared with open surgery. In this study, avoiding the uterine manipulator and using maneuvers to avoid tumor spread at the time of colpotomy in minimally invasive surgery was associated with similar outcomes to open surgery. Further prospective studies are warranted.

Indexed as

AdultAgedAged, 80 and overCohort StudiesEuropeFemaleHumansHysterectomyMiddle AgedMinimally Invasive Surgical ProceduresNeoplasm StagingUterine Cervical NeoplasmsYoung Adultcervix uterilaparoscopeslaparotomyneoplasm recurrence, localsurgical oncology

Identifiers

PMID32788262
OpenAlexW3048946584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.